Patents by Inventor Philip Scuderi

Philip Scuderi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD, COMPOSITION, AND ARTICLE OF MANUFACTURE FOR PROVIDING ALPHA-1 ANTITRYPSIN
    Publication number: 20240092868
    Abstract: The present invention provides a method for providing alpha-1 antitrypsin (?1-AT) to a subject, in particular a method for treating or preventing a disorder of disease associated with ?1-AT deficiency in the subject, wherein the method comprises providing, subcutaneously, a therapeutically or prophylactically effective amount of ?1-AT to the subject. Also provided is a composition and article of manufacture comprising ?1-AT, in particular a formulation suitable for subcutaneous administration of ?1-AT.
    Type: Application
    Filed: November 22, 2023
    Publication date: March 21, 2024
    Inventors: Vikram ARORA, Mohan PAMARTHI, Philip SCUDERI
  • METHOD, COMPOSITION, AND ARTICLE OF MANUFACTURE FOR PROVIDING ALPHA-1 ANTITRYPSIN
    Publication number: 20200172599
    Abstract: The present invention provides a method for providing alpha-1 antitrypsin (?1-AT) to a subject, in particular a method for treating or preventing a disorder or disease associated with ?1-AT deficiency in the subject, wherein the method comprises providing, subcutaneously, a therapeutically or prophylactically effective amount of ?1-AT to the subject. Also provided is a composition and article of manufacture comprising ?1-AT, in particular a formulation suitable for subcutaneous administration of ?1-AT.
    Type: Application
    Filed: November 27, 2019
    Publication date: June 4, 2020
    Inventors: Vikram Arora, Mohan Pamarthi, Philip Scuderi
  • Method of treatment and prophylaxis of diseases related to amyloid deposition using IgM
    Patent number: 8852585
    Abstract: The invention relates to a method of treating or preventing disease associated with ?-amyloid polypeptides comprising administration of an immunoglobulin preparation enriched in immunoglobulin M (IgM), and pharmaceutical compositions comprising such preparations.
    Type: Grant
    Filed: January 30, 2007
    Date of Patent: October 7, 2014
    Assignee: Grifols Therapeutics Inc.
    Inventors: Philip Scuderi, Jr., Afshin Safavi, Matthew G. Langevin
  • Recombinant plasmin for opthalmic indications
    Patent number: 8231869
    Abstract: Methods of using polynucleotides and polypeptides relating to a recombinantly-modified plasmin(ogen) molecule are provided, including methods related to vitrectomy or vitreolysis. The plasmin(ogen) molecule has a single kringel domain N-terminal to the activation site present in the native human plasminogen molecule, and exhibits lysine-binding and significant enzymatic characteristics associated with the native enzyme.
    Type: Grant
    Filed: October 18, 2006
    Date of Patent: July 31, 2012
    Assignee: Grifols Therapeutics Inc.
    Inventors: Philip Scuderi, Jr., Vikram Arora, Jennifer A. Hunt, Valery Novokhatny, Stephen R. Petteway, Jr.
  • METHOD, COMPOSITION, AND ARTICLE OF MANUFACTURE FOR PROVIDING ALPHA-1 ANTITRYPSIN
    Publication number: 20110002909
    Abstract: The present invention provides a method for providing alpha-1 antitrypsin (?1-AT) to a subject, in particular a method for treating or preventing a disorder or disease associated with ?1-AT deficiency in the subject, wherein the method comprises providing, subcutaneously, a therapeutically or prophylactically effective amount of ?1-AT to the subject. Also provided is a composition and article of manufacture comprising ?1-AT, in particular a formulation suitable for subcutaneous administration of ?1-AT.
    Type: Application
    Filed: October 31, 2008
    Publication date: January 6, 2011
    Inventors: Vikram Arora, Mohan Pamarthi, Philip Scuderi
  • RECOMBINANTLY MODIFIED PLASMIN
    Publication number: 20100047228
    Abstract: Methods of using polynucleotides and polypeptides relating to a recombinantly-modified plasmin(ogen) molecule are provided, including methods related to vitrectomy or vitreolysis. The plasmin(ogen) molecule has a single kringel domain N-terminal to the activation site present in the native human plasminogen molecule, and exhibits lysine-binding and significant enzymatic characteristics associated with the native enzyme.
    Type: Application
    Filed: October 18, 2006
    Publication date: February 25, 2010
    Inventors: Philip Scuderi, JR., Vikram Arora, Jennifer A. Hunt, Valery Novokhatny, Stephen R. Petteway, JR.
  • Method of Treatment and Prophylaxis of Diseases Related to Amyloid Deposition Using IGM
    Publication number: 20090269359
    Abstract: The invention relates to a method of treating or preventing disease associated with ?-amyloid polypeptides comprising administration of an immunoglobulin preparation enriched in immunoglobulin M (IgM), and pharmaceutical compositions comprising such preparations.
    Type: Application
    Filed: January 30, 2007
    Publication date: October 29, 2009
    Applicant: Talecris Biotherapeutics, Inc.
    Inventors: Philip Scuderi, JR., Afshin Safavi, Matthew G. Langevin
  • Complexes for transferring nucleic acids into cells
    Publication number: 20090022746
    Abstract: The invention relates to complexes of cationic polymers and nucleic acids, to the use of such complexes for introducing nucleic acids into cells and organisms, to the use of the complexes as pharmaceuticals, and to novel polymers which can be used to prepare the complexes.
    Type: Application
    Filed: June 21, 2007
    Publication date: January 22, 2009
    Inventors: Joachim Simon, Martin Vollmer, Ulrich Betz, Philip Scuderi
  • Complexes for transferring nucleic acids into cells
    Publication number: 20040048819
    Abstract: The invention relates to complexes of cationic polymers and nucleic acids, to the use of such complexes for introducing nucleic acids into cells and organisms, to the use of the complexes as pharmaceuticals, and to novel polymers which can be used to prepare the complexes. The polymers are preferably polyamines and more preferably polyethyleneimine.
    Type: Application
    Filed: September 5, 2003
    Publication date: March 11, 2004
    Inventors: Joachim Simon, Martin Vollmer, Ulrich Betz, Philip Scuderi
  • Indoor and outdoor air quality monitoring device with wired and wireless communication
    Patent number: D907514
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: January 12, 2021
    Assignee: AERNOS, INC.
    Inventors: Herve Lambert, Albert Chen, Philip Scuderi, Sundip Doshi, James Souers